End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.92 CNY | +0.39% | -0.96% | +1.25% |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- The company has a poor ESG score according to Refinitiv, which ranks companies by sector.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Non-Paper Containers & Packaging
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.25% | 2.37B | D | ||
+8.66% | 4.79B | B | ||
+18.98% | 3.89B | - | ||
-27.53% | 1.85B | B- | ||
-18.54% | 705M | C+ | ||
0.00% | 598M | - | - | |
-0.38% | 346M | - | - | |
-25.52% | 306M | - | - | |
-39.58% | 218M | - | - | |
-4.91% | 191M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 600529 Stock
- Ratings Shandong Pharmaceutical Glass Co.Ltd